Clinical trial
A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese…
NCT00406432 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00406432 |
|---|---|
| Title | A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects |
| Official title | A Steady-state Study to Assess the Pharmacokinetic Profile of Paroxetine After 14 Day Repeated Daily Dosing of the Controlled Release Paroxetine Tablet (25 mg) in Healthy Chinese Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | Paroxetine Controlled Release Tablet |
| Enrollment | 12 |
| Start date | May 9, 2006 |
| Primary completion | Jun 2, 2006 |
| Completion | Jun 2, 2006 |
| First posted | Dec 4, 2006 |
| Last update posted | Sep 29, 2017 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: